Paclitaxel (albumin-bound) Clinical Trials

4 actively recruiting trials

Pipeline

Phase 2: 2Phase 3: 1Phase 1/2: 1

Top Sponsors

Shanghai Yizhong Pharmaceutical Co., Ltd.1
Jiangsu Alphamab Biopharmaceuticals Co., Ltd1
Dai, Guanghai1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1

Indications

Cancer4
Breast Cancer2
Metastatic HER2-Negative Breast Cancer1
Inoperable Locally Advanced HER2-Negative Breast Cancer1
Metastatic Breast Cancer (MBC)1

Other4 trials

Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial Cancer

Phase 2

Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Metastatic Breast Cancer

Phase 3

Safety and Efficacy of Fruquintinib Plus Nab-Paclitaxel and Iparomlimab and Tuvonralimab Injection in the Second-Line Treatment for Immunotherapy-experienced Advanced Gastric Cancer

Phase 2

Study of JSKN016 Combination Therapy in Inoperable Locally Advanced or Metastatic HER2-Negative Breast Cancer

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.